文献速递湿疹皮炎与荨麻疹

FTO/SOCS6-m6A表观遗传轴通过调控角质形成细胞功能连接肥胖与特应性皮炎

FTO/SOCS6-m6A axis epigenetic modification links obesity to atopic dermatitis by regulating keratinocyte function.
PubMed 文献 · J Invest Dermatol · 2026-02-03

该研究探讨肥胖相关FTO上调在特应性皮炎(AD)中的作用机制。通过转录组与表观转录组测序,发现FTO选择性结合并去甲基化SOCS6 mRNA编码区的m6A修饰,降低SOCS6稳定性与蛋白表达,激活角质形成细胞炎症程序。局部敲低FTO可改善AD样病理并恢复SOCS6表达,提示FTO/SOCS6-m6A轴是肥胖与AD关联的关键表观遗传机制及潜在治疗靶点。

要点

  • 肥胖相关FTO在AD皮损角质形成细胞中上调,驱动AD病理。
  • FTO去甲基化SOCS6 mRNA编码区m6A,降低SOCS6稳定性与表达。
  • 局部敲低FTO可改善AD样病理并恢复SOCS6表达。

核心结论

  • FTO/SOCS6-m6A表观遗传轴是肥胖与AD关联的基本机制,其组分是精准AD管理的潜在治疗靶点。

研究设计与样本

  • 研究采用转录组与表观转录组测序分析,并在体内进行局部FTO敲低实验。

主要发现

  • 肥胖相关FTO在AD皮损角质形成细胞中上调,驱动AD病理。
  • FTO选择性结合并去甲基化SOCS6 mRNA编码区m6A修饰,降低SOCS6 mRNA稳定性与蛋白表达。
  • IL-1β、S100A8和S100A9是FTO/SOCS6-m6A轴的主要下游效应分子,促进角质形成细胞凋亡、屏障损伤和炎症。
  • 局部FTO敲低在体内改善AD样病理并恢复SOCS6表达。

临床怎么用

  • FTO/SOCS6-m6A轴组分可作为精准AD管理的潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Atopic dermatitis (AD) is characterized by epidermal barrier dysfunction and immune dysregulation. Notably, metabolic disorders such as obesity can influence AD susceptibility; however, the specific molecular drivers underlying this association, particularly those involving dysregulated RNA metabolism, remain incompletely understood. Our study demonstrates that obesity-associated upregulation of the N6-methyladenosine demethylase FTO (fat mass and obesity-associated) in lesional epidermis, specifically in keratinocytes, drives AD pathology. Integrated transcriptomic and epitranscriptomic sequencing analyses identified SOCS6 (suppressor of cytokine signaling 6) as a key FTO target. Mechanistically, FTO selectively binds and demethylates N6-methyladenosine modifications within the coding sequence of SOCS6 mRNA, reducing SOCS6 mRNA stability and protein expression. This site-specific epigenetic silencing activates inflammatory programs in keratinocytes. We further identified IL-1β, S100A8, and S100A9 as major downstream effectors of this FTO/SOCS6-N6-methyladenosine axis, promoting keratinocyte apoptosis, barrier impairment, and inflammation. Critically, topical FTO knockdown in vivo ameliorated AD-like pathology and restored SOCS6 expression, confirming FTO's causative role. Collectively, we elucidate the FTO/SOCS6-N6-methyladenosine epigenetic axis as a fundamental obesity-AD link, highlighting its components as promising therapeutic targets for precision AD management.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Xiao F, Wu R, Wu N, et al. FTO/SOCS6-m6A axis epigenetic modification links obesity to atopic dermatitis by regulating keratinocyte function. J Invest Dermatol. 2026. PMID: 41644088. doi:10.1016/j.jid.2026.01.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。